Valeant vs Endo: Who Will Win the Fight for Salix

The fight is one. Yesterday, Endo International (ENDP) announced it is bidding $175 a share in cash and stock for Salix Pharmaceuticals (SLXP), looking to interrupt the$158-a-share deal Valeant Pharmaceuticals International (VRX) announced on Feb. 22. The entry of another bidder was unexpected. And while Salix will have to at least consider the offer, few [...]